Y. Suenaga

发表

Transcriptional regulation of tumor suppressor p53 by cAMP‐responsive element‐binding protein/AMP‐activated protein kinase complex in response to glucose deprivation

A. Nakagawara, T. Ozaki, K. Ando, 2009, Genes to cells : devoted to molecular & cellular mechanisms.

ALK is a MYCN target gene and regulates cell migration and invasion in neuroblastoma

M. Ohira, Yohko Nakamura, A. Nakagawara, 2013, Scientific Reports.

Expression of NLRR3 Orphan Receptor Gene Is Negatively Regulated by MYCN and Miz-1, and Its Downregulation Is Associated with Unfavorable Outcome in Neuroblastoma

M. Ohira, A. Nakagawara, T. Ozaki, 2011, Clinical Cancer Research.

Expression of TSLC1, a candidate tumor suppressor gene mapped to chromosome 11q23, is downregulated in unfavorable neuroblastoma without promoter hypermethylation

M. Ohira, Yohko Nakamura, A. Nakagawa, 2008, International journal of cancer.

KIF1Bβ Functions as a Haploinsufficient Tumor Suppressor Gene Mapped to Chromosome 1p36.2 by Inducing Apoptotic Cell Death*

M. Ohira, A. Nakagawara, T. Ozaki, 2008, Journal of Biological Chemistry.

Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells

M. Ohira, A. Nakagawara, Y. Suenaga, 2015, Cancer science.

NCYM promotes calpain-mediated Myc-nick production in human MYCN-amplified neuroblastoma cells.

W. Shoji, A. Nakagawara, Y. Suenaga, 2015, Biochemical and biophysical research communications.

NCYM, a Cis-Antisense Gene of MYCN, Encodes a De Novo Evolved Protein That Inhibits GSK3β Resulting in the Stabilization of MYCN in Human Neuroblastomas

W. Shoji, T. Shibata, M. Ohira, 2014, PLoS genetics.

RUNX3 Modulates DNA Damage-mediated Phosphorylation of Tumor Suppressor p53 at Ser-15 and Acts as a Co-activator for p53*

A. Nakagawara, T. Ozaki, K. Ando, 2010, The Journal of Biological Chemistry.

A. Ishigami, Y. Suenaga, Yoshiro Kobayashi, 2020, Biochemical and biophysical research communications.

Inactivation of beta1 integrin induces proteasomal degradation of Myc oncoproteins

H. Kodama, Y. Suenaga, T. Iyoda, 2019, Oncotarget.

Combining peptide TNIIIA2 with all-trans retinoic acid accelerates N-Myc protein degradation and neuronal differentiation in MYCN-amplified neuroblastoma cells.

H. Kodama, Y. Higami, Y. Suenaga, 2019, American journal of cancer research.

TATA-binding protein-related factor 2 is localized in the cytoplasm of mammalian cells and much of it migrates to the nucleus in response to genotoxic agents.

Y. Suenaga, Yuji Tanaka, Taka‐aki Tamura, 2006, Molecules and cells.

Sp1‐mediated transcriptional regulation of NFBD1/MDC1 plays a critical role in DNA damage response pathway

A. Nakagawara, T. Ozaki, Fangzhou Song, 2007, Genes to cells : devoted to molecular & cellular mechanisms.

Protein-coding potential of RNAs measured by potentially translated island scores

T. Makino, Y. Suenaga, Mamoru Kato, 2021, bioRxiv.

Potentially translated sequences determine protein-coding potential of RNAs in cellular organisms

T. Makino, Y. Suenaga, Mamoru Kato, 2021 .

Positive auto-regulation of MYCN in human neuroblastoma.

A. Nakagawara, T. Ozaki, Y. Suenaga, 2009, Biochemical and biophysical research communications.

Open reading frame dominance indicates protein‐coding potential of RNAs

T. Makino, Y. Suenaga, Mamoru Kato, 2022, EMBO reports.

Functional interplay between MYCN, NCYM, and OCT4 promotes aggressiveness of human neuroblastomas

M. Ohira, Yohko Nakamura, A. Nakagawara, 2015, Cancer science.

MicroRNA induction by copy number gain is associated with poor outcome in squamous cell carcinoma of the lung

I. Yoshino, Y. Suenaga, T. Iizasa, 2018, Scientific Reports.

TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma.

M. Ohira, A. Nakagawara, T. Ozaki, 2019, Biochemical and biophysical research communications.

De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers.

A. Nakagawara, Y. Suenaga, Kazuma Nakatani, 2020, Japanese journal of clinical oncology.

NLRR1 enhances EGF-mediated MYCN induction in neuroblastoma and accelerates tumor growth in vivo.

Yusuke Suenaga, Akira Nakagawara, Yohko Nakamura, 2012, Cancer research.

TATA-binding Protein (TBP)-like Protein Is Engaged in Etoposide-induced Apoptosis through Transcriptional Activation of Human TAp63 Gene*

A. Nakagawara, T. Ozaki, Y. Bu, 2009, The Journal of Biological Chemistry.

TAp63-dependent induction of growth differentiation factor 15 (GDF15) plays a critical role in the regulation of keratinocyte differentiation

A. Nakagawara, T. Ozaki, Y. Suenaga, 2008, Oncogene.

CEP131 Abrogates CHK1 Inhibitor-Induced Replication Defects and Is Associated with Unfavorable Outcome in Neuroblastoma

M. Makishima, H. Nagase, K. Ando, 2020, Journal of oncology.

NFBD1/MDC1 participates in the regulation of G2/M transition in mammalian cells.

A. Nakagawara, T. Ozaki, Fangzhou Song, 2010, Biochemical and biophysical research communications.

DeltaNp63/BMP-7-dependent expression of matrilin-2 is involved in keratinocyte migration in response to wounding.

A. Nakagawara, T. Ozaki, Y. Suenaga, 2008, Biochemical and biophysical research communications.

FGFR2 loss sensitizes MYCN‐amplified neuroblastoma CHP134 cells to CHK1 inhibitor–induced apoptosis

M. Makishima, M. Ohira, H. Nagase, 2021, Cancer science.

Global changes in open reading frame dominance of RNAs during cancer initiation and progression

Y. Suenaga, M. Kawazu, Y. Hippo, 2023, bioRxiv.

DNA Ligase 4 Contributes to Cell Proliferation against DNA-PK Inhibition in MYCN-Amplified Neuroblastoma IMR32 Cells

K. Ando, T. Kamijo, Y. Suenaga, 2023, International journal of molecular sciences.

Secondary Structure of Human De Novo Evolved Gene Product NCYM Analyzed by Vacuum-Ultraviolet Circular Dichroism

Y. Suenaga, T. Tamada, T. Matsuo, 2021, Frontiers in Oncology.

Temozolomide suppresses MYC via activation of TAp63 to inhibit progression of human glioblastoma

M. Ohira, A. Nakagawara, Y. Suenaga, 2013, Scientific Reports.

Plk1 regulates liver tumor cell death by phosphorylation of TAp63

A. Iwama, A. Nakagawara, T. Ozaki, 2009, Oncogene.